Evaluation of a Screen and Treat Protocol for Influenza - Trial NCT06207058
Access comprehensive clinical trial information for NCT06207058 through Pure Global AI's free database. This phase not specified trial is sponsored by Tricore, Inc and is currently Not yet recruiting. The study focuses on Influenza. Target enrollment is 600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Tricore, Inc
Timeline & Enrollment
N/A
Jan 15, 2024
Jul 01, 2024
Primary Outcome
Mitigation of Influenza Transmission
Summary
This study seeks to demonstrate that the laboratory can mitigate respiratory virus
 transmission in underserved populations by using laboratory data to identify communities at
 risk for increase vial activity (hot spots) and intervening with a test-to-treat model
 provides increased access to influenza diagnostics and treatment in vulnerable and
 underserved communities.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06207058
Non-Device Trial